Rheumatoid Arthritis (RA) is a chronic autoimmune disease characterized by progressive joint inflammation and damage. Oxidative stress plays a critical role in the onset and progression of RA, significantly contributing to the disease’s symptoms. The complex nature of RA and the role of oxidative stress make it particularly challenging to treat effectively. This article presents a comprehensive review of RA’s development, progression, and the emergence of novel treatments, introducing Galangin (GAL), a natural flavonoid compound sourced from various plants, as a promising candidate. The bioactive properties of GAL, including its anti-inflammatory, antioxidant, and immunomodulatory effects, are discussed in detail. The review elucidates GAL’s mechanisms of action, focusing on its interactions with key targets such as inflammatory cytokines (e.g., TNF-α, IL-6), enzymes (e.g., SOD, MMPs), and signaling pathways (e.g., NF-κB, MAPK), which impact inflammatory responses, immune cell activation, and joint damage. The review also addresses the lack of comprehensive understanding of potential treatment options for RA, particularly in relation to the role of GAL as a therapeutic candidate. It highlights the need for further research and clinical studies to ascertain the effectiveness of GAL in RA treatment and to elucidate its mechanisms of action. Overall, this review provides valuable insights into the potential of GAL as a therapeutic option for RA, shedding light on its multifaceted pharmacological properties and mechanisms of action, while suggesting avenues for future research and clinical applications.

This study focused on the isolation, characterization, and evaluation of the antimicrobial and antioxidant activities of a crude extract from Bacillus subtilis isolated from rhizosphere soil. Through biochemical and physiological assessments, followed by whole genome sequencing, the isolate was confirmed as Bacillus subtilis BSP1. We examined the antimicrobial activity of B. subtilis BSP1 metabolites against various pathogenic bacteria and fungi. To enhance its antibacterial efficacy, we optimized the fermentation medium to maximize the secretion of antibacterial agents. Our findings demonstrated that the crude extract exhibited notable antimicrobial properties against various pathogenic bacterial and fungal isolates. The antioxidant test revealed a dose-dependent increase in the extract’s DPPH scavenging activity and reducing power, with an impressive 98.9% DPPH scavenging activity at 30 mg/mL. Importantly, safety assessments indicated a lack of hemolytic activity on human red blood cells, with only 1.3% hemolysis at 100 mg/mL, suggesting its potential suitability for practical applications. In summary, Bacillus subtilis BSP1, isolated from soil, appears to be a promising candidate for antibiotic production. Its significant antimicrobial and antioxidant properties, combined with its safety profile, highlight its potential applications in medicine, agriculture, and biotechnology.